Clinical and Translational Allergy

Papers
(The H4-Index of Clinical and Translational Allergy is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
107
EczemaPred: A computational framework for personalised prediction of eczema severity dynamics100
Course of IgE to α‐Gal in a Swedish population of α‐Gal syndrome patients40
Real‐life data on inactivated COVID‐19 vaccination in patients with subcutaneous allergen immunotherapy37
Reducing severe cutaneous adverse and type B adverse drug reactions using pre‐stored human leukocyte antigen genotypes37
Effectiveness of Ectoin lozenges on oropharyngeal allergic symptoms34
Genomic evidence for dysregulated glutamine metabolism in the asthmatic airway epithelium33
Issue Information31
30
Elevated PLAUR is observed in the airway epithelium of asthma patients and blocking improves barrier integrity30
30
Issue Information29
28
27
Gut microbial alteration in chronic spontaneous urticaria unresponsive to second generation antihistamines and its correlation with disease characteristics‐ a cross‐sectional case‐control study26
26
Prednisolone versus antihistamine for allergic rhinitis: No significant difference found in randomized trial25
Recent advances in research on common targets of neurological and sex hormonal influences on asthma24
Anti‐polyethylene glycol (PEG) antibody isotypes may predict PEG‐associated allergy and COVID‐19 protection among patients with history of suspected COVID‐19 vaccine allergy23
Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune21
The use of patient‐reported outcome measures by healthcare professionals in specialized asthma management centers in French‐speaking Belgium: A mixed‐methods study20
Physicians' needs for drug allergy documentation in electronic health records and allergy alert systems: Results of an end user's survey20
0.038295030593872